Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.

RADICAL PROSTATECTOMY FOR LOCALIZED PROSTATE CANCER PROVIDES DURABLE CANCER CONTROL WITH EXCELLENT QUALITY OF LIFE: A STRUCTURED DEBATE

WALSH, PATRICK C. · 2000 · Journal of Urology

Abstract

PURPOSE: To cure localized prostate cancer, the entire prostate must be eliminated, which is what all forms of treatment must achieve. Although there is no better way to cure localized disease than total surgical removal, the challenge is whether this can be accomplished with acceptable morbidity. MATERIALS AND METHODS: To evaluate quality of life following radical retropubic prostatectomy, patient reported outcomes of 62 men who underwent radical retropubic prostatectomy at this institution were recorded during the first 18 months of followup. By 18 months 93% of the patients were dry (wearing no pads) and 93% to 98% characterized urinary bothersomeness as none or small. Potency, defined as the ability to achieve unassisted intercourse with or without the use of sildenafil, improved gradually and by 18 months 86% of the patients were potent and 84% considered sexual bothersomeness as none or small. In an effort to improve the outcome of radical prostatectomy, the surgical procedures on these 62 patients were videotaped prospectively. The videotapes were reviewed 18 months after the study was initiated and 4 specific steps in the surgical procedure were correlated with patient reported outcomes. Surgeons who wish to improve their outcomes should consider using this technique to identify in their own hands other important arbitrary variations that may improve results. RESULTS: The probability of maintaining an undetectable prostate specific antigen was evaluated in men with similar pathological stages of disease who were or were not potent following surgery. Men who were potent had the same outcome as those who were impotent, supporting the premise that preservation of sexual function does not compromise cancer control. Cancer control and quality of life following brachytherapy were analyzed and the following conclusions were made: 1) high dose intensification is necessary if radiation therapy is expected to cure prostate cancer but I doubt that any form of radiotherapy will produce durable cancer control for 20 to 30 years; 2) although brachytherapy is rarely adequate as monotherapy, I am not certain that brachytherapy combined with external beam radiotherapy is any better than 3-dimensional conformal therapy alone and the side effects are uncertain, and 3) I believe that a prostate specific antigen nadir of less than 0.2 ng./ml. is necessary to confirm an adequate response to radiation. CONCLUSIONS: I believe that there is no better way to cure organ confined cancer than total surgical removal. Today continence and potency rates should be high. If not, a review of intraoperative videotapes of successful and unsuccessful cases can improve results. In men treated with radiotherapy stringent criteria for treatment response and quality of life outcomes are needed.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0022-5347(05)67547-7

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 36 references

Research works printed but not linked: 3

  1. Palapattu, 1996, A change in the technique of radical retropubic prostatectomy markedly improves postoperative potency, J Urol, 155, 647A
  2. Ragde, 1997, Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma, Cancer, 80, 442, 10.1002/(SICI)1097-0142(19970801)80:3<442::AID-CNCR12>3.0.CO;2-X · doi:10.1002/(sici)1097-0142(19970801)80:3<442::aid-cncr12>3.0.co;2-x
  3. Talcott, 1999, Long-term treatment-related complications of brachytherapy for early prostate cancer: a survey of treated patients, Proc ASCO, 18, 311a

Cited by

See all 261

Metadata

Authors
WALSH, P. C.
Affiliations
Johns Hopkins University (US)
Corresponding author
WALSH, PATRICK C.
Venue
Journal of Urology
Published
2000-06
Volume
163
Issue
6
Pages
1802-1807
ISSN
  • 0022-5347 (ISSN-L)
  • 1527-3792
OpenAlex
W2153314120
Cited by
261
References
36
Citations by year
2025: 1 · 2024: 6 · 2023: 1 · 2022: 1 · 2021: 5 · 2020: 1 · 2019: 4 · 2018: 3 · 2017: 5 · 2016: 5 · 2015: 1 · 2014: 8 · 2013: 10 · 2012: 8
FWCI
17.64
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Journal of Urology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
  • Health Sciences › Medicine › Urology › Urinary Bladder and Prostate Research
Keywords
localized prostate cancer, radical retropubic prostatectomy, quality of life, erectile function, sexual function preservation, urinary continence, prostate-specific antigen, brachytherapy, external beam radiotherapy, 3D conformal radiotherapy, cancer control, surgical technique, patient-reported outcomes, postoperative morbidity, prostate cancer treatment outcomes
MeSH terms
Adenocarcinoma, Brachytherapy, Humans, Erectile Dysfunction, Male, Prostatectomy, Prostatic Neoplasms, Quality of Life, Time Factors, Urinary Incontinence, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: RADICAL PROSTATECTOMY FOR LOCALIZED PROSTATE CANCER PROVIDES DURABLE CANCER CONTROL WITH EXCELLENT QUALITY OF LIFE: A STRUCTURED DEBATE. https://app.cochat.ai/papers/10.1016/s0022-5347(05)67547-7
The paper
WALSH, P. C. (2000). RADICAL PROSTATECTOMY FOR LOCALIZED PROSTATE CANCER PROVIDES DURABLE CANCER CONTROL WITH EXCELLENT QUALITY OF LIFE: A STRUCTURED DEBATE. Journal of Urology. https://doi.org/10.1016/s0022-5347(05)67547-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.